Sophia Paspal

Plus aucun poste en cours

Health Technology

Consumer Services

Profil

Sophia Paspal worked as a Director of Regulatory Affairs & Oncology at Halozyme Therapeutics, Inc. from 2015 to 2017.
Prior to that, she was an Associate Director of Regulatory Affairs & Neurology at Dart NeuroScience LLC in 2014-2015.
Dr. Paspal also served as the Chief Development Officer at Xynomic Pharmaceuticals Holdings, Inc. Dr. Paspal received her undergraduate and doctorate degrees from the University of Minnesota.

Anciens postes connus de Sophia Paspal

Sociétés	Poste	Fin
HALOZYME THERAPEUTICS, INC.	Corporate Officer/Principal	01/01/2017
Dart NeuroScience LLC Dart NeuroScience LLC Pharmaceuticals: MajorHealth Technology Develops drugs to improve memory	Corporate Officer/Principal	01/01/2015
XYNOMIC PHARMACEUTICALS HOLDINGS, INC.	Directeur Technique/Scientifique/R&D	-

Voir l'expérience en détail de Sophia Paspal

Formation de Sophia Paspal

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Sophia Paspal

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	4
Halozyme Therapeutics, Inc. Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets	Health Technology
University of Minnesota University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Dart NeuroScience LLC Dart NeuroScience LLC Pharmaceuticals: MajorHealth Technology Develops drugs to improve memory	Health Technology
Xynomic Pharmaceuticals Holdings, Inc. Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and supplies oncology drugs	Health Technology